Citations

Clear

426 citation(s) found for "ST, Reza".

Non-invasive detection of cardiac allograft rejection among heart transplant recipients using an electrocardiogram based deep learning model
Adedinsewo, Demilade , Hardway, Heather D , Morales-Lara, Andrea Carolina , Wieczorek, Mikolaj A. , Douglass, Erika J. , Dangott, Bryan, Nakhleh, Raouf E. , Narula, Tathagat , Patel, Parag C. , Lyle, Melissa , Heckman, Alexander , Leoni-Moreno, Juan Carlos, Steidley, D. Eric , Hardaway, Brian , Abbas, Mohsin, Friedman, Paul A. , Carter, Rickey E. , Yamani, Mohamad H. , Douglass, Erika J , Dangott, Bryan J, Narula, Tathagat , Heckman, Alexander J, Leoni-Moreno, Juan C, Attia, Zachi I , Lopez-Jimenez, Francisco , Yamani, Mohamad, Carter, Rickey E , Adedinsewo, Demilade A , Hardway, Heather , Johnson, Patrick W. , Goswami, Rohan , Arsanjani, Reza , Behfar, Atta , Attia, Zachi I. , López-Jiménez, Francisco , Noseworthy, Peter A.

Mayo Clinic

European Heart Journal - Digital Health | January 13, 2023 | Volume: 4 | Issue: 2 | Pages: 71-80

10.1093/ehjdh/ztad001 | PMID 36974261 Get It

Abstract Aims Current non-invasive screening methods for cardiac allograft rejection have shown limited discrimination and are yet to be broadly integrated into heart transplant care. Given electrocardiogram (ECG) changes have been reported with severe cardiac allograft rejection, this study aimed to develop a deep-learning model, a form of artificial intelligence, to detect allograft rejection using the 12-lead ECG (AI-ECG). Methods and results Heart transplant recipients were identified across three Mayo Clinic sites between 1998 and 2021. Twelve-lead digital ECG data and endomyocardial biopsy results were extracted from medical records. Allograft rejection was defined as moderate or severe acute cellular rejection (ACR) based on International Society for Heart and Lung Transplantation guidelines. The extracted data (7590 unique ECG-biopsy pairs, belonging to 1427 patients) was partitioned into training (80%), validation (10%), and test sets (10%) such that each patient was included in only one partition. Model performance metrics were based on the test set (n = 140 patients; 758 ECG-biopsy pairs). The AI-ECG detected ACR with an area under the receiver operating curve (AUC) of 0.84 [95% confidence interval (CI): 0.78–0.90] and 95% (19/20; 95% CI: 75–100%) sensitivity. A prospective proof-of-concept screening study (n = 56; 97 ECG-biopsy pairs) showed the AI-ECG detected ACR with AUC = 0.78 (95% CI: 0.61–0.96) and 100% (2/2; 95% CI: 16–100%) sensitivity. Conclusion An AI-ECG model is effective for detection of moderate-to-severe ACR in heart transplant recipients. Our findings could improve transplant care by providing a rapid, non-invasive, and potentially remote screening option for cardiac allograft function.
DNA polymerase theta protects leukemia cells from metabolic-induced DNA damage
Vekariya, Umeshkumar , Toma, Monika M. , Nieborowska-Skorska, Margaret , Le, Bac Viet , Caron, Marie‐Christine, Kukuyan, Anna-Mariya, Sullivan-Reed, Katherine , Podszywalow‐Bartnicka, Paulina , Chitrala, Kumaraswamy Naidu , Atkins, Jessica , Feng, Wanjuan, Chatla, Srinivas , Golovine, Konstantin, Jelı́nek, Jaroslav , Ghosh, Jayashri , Matlawska‐Wasowska, Ksenia , Chandramouly, Gurushankar , Nejati, Reza , Wasik, Mariusz A. , Sykes, Stephen M. , Pomerantz, Richard T. , Morton, George , Paietta, Elisabeth , Levine, Ross L. , Tallman, Martin S. , Fernández, Hugo F. , Litzow, Mark R. , Toma, Monika , Drzewiecka, Malgorzata , Chan, Joe , Chatla, Srinivas , Jelinek, Jaroslav , Ghosh, Jayashri , Matlawska-Wasowska, Ksenia , Sykes, Stephen M , Hadzijusufovic, Emir , Valent, Peter , Childers, Wayne , Fernandez, Hugo , Litzow, Mark R. , Gupta, Gaorav P , Drzewiecka, Małgorzata , Śliwiński, Tomasz , Piwocka, Katarzyna , Valent, Peter , Zhao, Huaqing , Masson, Jean‐Yves , Skórski, Tomasz

Mayo Clinic

Blood | December 29, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1182/blood.2022018428 | PMID 36580665 Get It

Leukemia cells accumulate DNA damage but altered DNA repair mechanisms protect them from apoptosis. We showed here that formaldehyde generated by serine/one-carbon cycle metabolism contributed to accumulation of toxic DNA-protein crosslinks (DPCs) in leukemia cells, especially in driver clones harboring oncogenic tyrosine kinases [OTKs: FLT3(ITD), JAK2(V617F), BCR/ABL1]. To counteract this effect, OTKs enhanced the expression of DNA polymerase theta (POLq) by ERK1/2 serine/threonine kinase-dependent inhibition of c-CBL E3 ligase-mediated ubiquitination of POLq and its proteasomal degradation. Overexpression of POLq in OTK-positive cells resulted in efficient repair of DPC-containing DNA double-strand breaks (DSBs) by POLq-mediated end-joining (TMEJ). Transforming activity of OTKs and other leukemia-inducing oncogenes, especially of those causing inhibition of BRCA1/2 -mediated homologous recombination (HR) with and without concomitant inhibition of DNA-PK -dependent non-homologous end-joining (D-NHEJ), was abrogated in Polq-/- murine bone marrow cells. Genetic and pharmacological targeting of POLq polymerase and helicase activities revealed that both activities are promising targets in leukemia cells. Moreover, OTK inhibitor or DPC-inducing drug etoposide enhanced anti-leukemia effect of POLq inhibitor (POLqi) in vitro and in vivo. In conclusion, we demonstrated that POLq plays an essential role in protecting leukemia cells from metabolically induced toxic DNA lesions triggered by formaldehyde and that it can be targeted to achieve therapeutic effect.
Impact of Persistent Iatrogenic Atrial Septal Defect following MitraClip
Seri, Amith Reddy , Abraham, Bishoy, Farina, Juan M. , Fennelly, Evelyn , Campany, Megan , Pereyra, Milagros , Said, Ebram F, Kenyon, Courtney , Fath, Ayman R. , Smith, Sean D. , Buckner‐Petty, Skye , Rayfield, Corbin, Fortuin, David, Sweeney, John P., Eleid, Mackram F. , Rihal, Charanjit S. , Holmes, David R. , Pollak, Peter , Sabbagh, Abdallah El , Oh, Jae K. , Arsanjani, Reza , Seri, Amith , Farina, Juan M , Pereyra, Milagros , Smith, Sean , Buckner-Petty, Skye, Rayfield, Corbin A, Pollak, Peter M, Arsanjani, Reza , Kenyon, Courtney R , Chao, Chieh‐Ju , Abraham, Bishoy , Yang, Eric H. , Alkhouli, Mohamad , Rihal, Charanjit S.

Mayo Clinic

Journal of Cardiovascular Development and Disease | December 23, 2022 | Volume: 10 | Issue: 1 | Pages: 1

10.3390/jcdd10010001 | PMID 36661896 Get It

Background: Prior studies have reported conflicting results of persistent iatrogenic atrial septal defect (iASD) and its impact following a transcatheter edge-to-edge repair (TEER) procedure. This study aims to evaluate the incidence of iASD and its clinical and hemodynamic impact after a TEER. Methods: Consecutive patients who underwent a TEER procedure from June 2014 to September 2020 at the Mayo Clinic were identified. The presence of iASD was retrospectively identified on post-procedure transthoracic echocardiography (TTE) to group patients into an iASD+ group and an iASD− group for comparison of prognosis and cardiac function. Results: A total of 316 patients were included; the mean age was 79.1 ± 9.1 years, and 67.7% were male. Persistent iASD was diagnosed in 108 (34.2%) patients. There was no difference concerning all-cause mortality, heart failure hospitalization, and stroke/TIA between groups at follow-up (median follow-up of 9 months). Post-procedure TTE demonstrated no differences regarding right ventricle (RV) and left ventricle (LV) dimensions and function, including TAPSE (15.2 ± 4.6 vs. 15.4 ± 5.5 mm, p = 0.875), and LV ejection fraction (51.1 ± 14.0% vs. 51.3 ± 13.9%, p = 0.933). However, patients with iASD had higher RV systolic pressure (48.7 ± 14.4 vs. 45.5 ± 14.5 mmHg, p = 0.042) compared with patients without iASD. Conclusion: Notwithstanding higher RV pressures, patients with persistent iASD had no hemodynamic compromise and an equal prognosis compared with those without a residual atrial defect after a TEER procedure. These findings support the mid-term safety of procedures in which an interatrial defect needs to be created and would argue against the need for interventional closure.
Abstract 431: MaxSpliZer: A Tool To Predict Effects Of LDLR Splice Variants Based On The Maximum Entropy Model
Shahnazar, Reza , Alhalabi, Lubna, Miller, Alexandra , Marwan, Hamed, Kullo, Iftikhar, Saadatagah, Seyedmohammad , Sherafati, Alborz

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | November 30, 2022 | Volume: 42 | Issue: Suppl_1 | Pages: No page available

10.1161/atvb.42.suppl_1.431 Get It

Background: The Clinical Genome Resource Consortium (ClinGen) recommends MaxEntScan (MES) model to predict the effects of LDLR splice variants. We developed “MaxSpliZer”, a software tool to automate the implementation of MES, and validated it using ClinVar and UK-Biobank (UKBB) data. Method: We tested concordance of MaxSpliZer predictions with ClinVar classifications of benign/likely benign (B/LB) and pathogenic/likely pathogenic (P/LP) for LDLR variants with potential effect on splicing. We also annotated LDLR splice variants in 200,618 UKBB participants, categorizing them using MaxSpliZer as deleterious (n=90) and non-deleterious (n=7,404). Low-density lipoprotein cholesterol (LDL-C) levels were compared in these two groups after adjustment for lipid-lowering medication use. Results: MaxSpliZer prediction was concordant with the ClinVar classification in 128 of 138 P/LP variants (sensitivity 93%) and 432 of 436 B/LB variants (specificity 99%). In the UKBB, splice variants predicted as deleterious by MaxSpliZer had higher LDL-C than non-deleterious splice variants (158.7±47.4 vs. 146.0±34.8mg/dL, p-value = 0.014). Compared to manual curation time of 12±7 min per variant, MaxSpliZer took 0.52±0.11 min for single entries and 1.5 s per variant for biobank-scale data. Conclusion: MaxSpliZer, a software tool that implements MES based on the ClinGen guideline, can accurately classify LDLR splice variants in a rapid automated fashion.
Tobacco Consumption Patterns among Iranian Adults: a National and Sub-national Update from the STEPS Survey 2021
Ghanbari, Ali , Ghamari, Seyyed‐Hadi , Rashidi, Mohammad‐Mahdi , Maleki, Ali , Abbasi-Kangevari, Zeinab , Rezaei, Nazila , Mehr, Elmira Foroutan, Moghimi, Mana, Rezaei, Nazila , Abbasi‐Kangevari, Mohsen , Malekpour, Mohammad‐Reza , Masinaei, Masoud , Ahmadi, Naser , Naderian, Mohammadreza , Fattahi, Nima , Rezaei, Negar , Farzadfar, Farshad

Mayo Clinic

No container title available | November 30, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2289653/v1 Get It

Abstract Background and objective Smoking is recognised as a critical public health priority due to its enormous health and economic consequences. Constant monitoring of the effectiveness of tobacco control programs calls for timely population-based data. This study reports the national and sub-national patterns in tobacco consumption among Iranian adults based on the results from the STEPwise approach to chronic disease risk factor surveillance (STEPS) survey 2021. Methods This study was performed through an analysis of the results of the STEPS survey 2021 which had been conducted as a nationally representative cross-sectional study. Participants included Iranian adults aged ≥ 18 years in all provinces of Iran, who were selected via multistage cluster sampling method. Data were analyzed via survey analysis while considering population weights. Results The total number of participants was 27874, including 15395 (55.23%) women and 12479 (44.77%) men. The all-ages prevalence (95% CI) of current tobacco smoking was 14.01% (13.56–14.48): 4.44% (4.09–4.82) among women and 25.88% (25.03–26.75) among men. The all-ages prevalence of current cigarette smoking was 9.33% (8.95–9.72): 0.77% (0.62–0.95) among women and 19.95% (19.17–20.75) among men. The all-ages prevalence of current hookah smoking was 4.5% (4.23–4.78): 3.64% (3.33, 3.98) among women and 5.56% (5.12–6.03) among men. The mean (SD) number of cigarettes smoked per day among current cigarettes smokers was 11.4 (9.82): 5.9 (6.76) among women and 11.65 (9.87) among men. The mean (SD) monthly times of hookah use was 23.87 (44.95): 29.93 (48.26) among women and 19.02 (41.52) among men. The national all-ages prevalence of second-hand smoking at home was 24.65 (24.06–25.25): 27.39 (26.6-28.19) among women and 20.28 (19.4-21.18) among men. The national all-ages prevalence of second-hand smoking at work was 20.73% (20.11–21.36): 17.96% (17.21–18.73) among women and 25.15% (24.07–26.26) among men. Conclusion The tobacco consumption in Iran remains alarmingly high, indicating the current tobacco control policy implementation level is ineffective and insufficient. This calls for adopting, implementing, and enforcing comprehensive packages of evidence-based tobacco control policies.
Multi-modal fusion model for predicting adverse cardiovascular outcome post percutaneous coronary intervention
Bhattacharya, Amartya , Sadasivuni, Sudarsan , Chao, Chieh-Ju, Agasthi, Pradyumna , Holmes, David R. , Sanyal, Arindam , Banerjee, Imon , Banerjee, Imon , Chao, Chieh‐Ju , Arsanjani, Reza

Mayo Clinic

Physiological Measurement | November 1, 2022 | Volume: 43 | Issue: 12 | Pages: 124004

10.1088/1361-6579/ac9e8a | PMID 36317320 Get It

Abstract Background. Clinical medicine relies heavily on the synthesis of information and data from multiple sources. However, often simple feature concatenation is used as a strategy for developing a multimodal machine learning model in the cardiovascular domain, and thus the models are often limited by pre-selected features and moderate accuracy. Method. We proposed a two-branched joint fusion model for fusing the 12-lead electrocardiogram (ECG) signal data with clinical variables from the electronic medical record (EMR) in an end-to-end deep learning architecture. The model follows the joint fusion scheme and learns complementary information from ECG and EMR. Retrospective data from the Mayo Clinic Health Systems across four sites for patients that underwent percutaneous coronary intervention (PCI) were obtained. Model performance was assessed by area under the receiver-operating characteristics (AUROC) and Delong’s test. Results. The final cohort included 17,356 unique patients with a mean age of 67.2 ± 12.6 year (mean ± std) and 9,163 (52.7%) were male. The joint fusion model outperformed the ECG time-domain model with statistical margin. The model with clinical data obtained the highest AUROC for all-cause mortality (0.91 at 6 months) but the joint fusion model outperformed for cardiovascular outcomes - heart failure hospitalization and ischemic stroke with a significant margin (Delong’s p < 0.05). Conclusion. To the best of our knowledge, this is the first study that developed a deep learning model with joint fusion architecture for the prediction of post-PCI prognosis and outperformed machine learning models developed using traditional single-source features (clinical variables or ECG features). Adding ECG data with clinical variables did not improve prediction of all-cause mortality as may be expected, but the improved performance of related cardiac outcomes shows that the fusion of ECG generates additional value.
Pulmonary vein anatomical variants and incidence of atrial fibrillation
Gallen, Rory , Apolinario, Michael , Panse, Prasad M., Jokerst, Clint , Sorajja, Dan , Arsanjani, Reza

Mayo Clinic

European Heart Journal | October 15, 2022 | Volume: 43 | Issue: Supplement_2 | Pages: No page available

10.1093/eurheartj/ehac544.355 Get It

Abstract Introduction Atrial fibrillation (AF) is the most common arrhythmia worldwide. The role of the pulmonary veins (PV) in its' pathogenesis has been well described, as have the most frequently seen anatomical variants of these veins. Prior studies have shown conflicting evidence on the potential association of PV variants and incidence of AF. We sought to reassess this association. Methods We conducted a retrospective case-control study of patients with AF (cases) and without AF (control group) undergoing cardiac CT imaging. We documented patient characteristics and cardiac anatomical features including PV variants, LV ejection fraction (EF) and left atrial (LA) volume/diameter. Results 295 patients were included: 194 with AF and 101 without. 71% of AF cases were male. We showed a numerical difference for PV variants between the AF and control group that was not statistically significant (48.5% and 39.6%, p=0.15). The overall incidence of PV variants was higher than in previous studies. A significant association was identified between left atrial appendage (LAA) morphology and incidence of AF. Conclusion The suggested association between PV anatomical variants and the pathogenesis of AF may not be as clear-cut as previously thought. Our study is one of the largest of its kind and provides conflicting evidence with prior studies in this area. An improved understanding of the complex pathophysiology of AF and its relation to the pulmonary veins may help to guide future preventative and therapeutic strategies. Funding Acknowledgement Type of funding sources: None.
Topological data analysis identified prognostically-distinct phenotypes in MitraClip patients
Chao, Christine P. , Seri, Amith Reddy , Fortuin, F. David , Sweeney, John P., Thaden, Jeremy J. , Eleid, M, Alkhouli, M.A, Rihal, C R, Holmes, David R. , Pollak, Peter , El‐Sabbagh, Abdallah, Lester, S J, Oh, J K, Banerjee, Imon , Arsanjani, Reza

Mayo Clinic

European Heart Journal | October 15, 2022 | Volume: 43 | Issue: Supplement_2 | Pages: No page available

10.1093/eurheartj/ehac544.1578 Get It

Abstract Background Topological data analysis (TDA) is the state-of-the-art unsupervised machine learning framework that can provide insight into the dataset and visualize condensed information via the topological network graph. This robust approach was never used to assess the heterogeneous MitraClip population. Purpose We aim to develop a TDA model that will identify prognostically-distinct phenogroups in MitraClip patients without a priori knowledge of the population and their outcomes. Method Patients who underwent MitraClip (June 2014-September 2020) at Mayo Clinic sites were identified from the institutional database for baseline and follow-up data. Thirteen variables were used for TDA. The topological network graph was created using the Python Scikit-TDA Kepler-Mapper package (v. 2.0.1), and clustering was performed at the graph level with Louvain's modularity method. Kaplan-Meier survival analysis was used to assess the all-cause mortality endpoint of each cluster identified in an unsupervised manner. The dataset with cluster labels was also used to train a Light Gradient Boosted Machine model, and SHapley Additive exPlanations (SHAP) analysis was applied to determine the feature importance. Results A total of 389 consecutive patients were included in the final analysis and two major clusters consisting of 384 patients were identified. The mean age was 80.3±8.7 years; 256 (65.8%) were male. The mean Society of Thoracic Surgeons Mitral Valve Replacement risk score was 9.6±6.9%. Fifty-five (14.5%) patients died during the mean follow duration (185 days). Kaplan-Meier analysis showed significant survival differences among the two clusters (HR: 2.38; 95% CI: 1.39–4.06, p=0.001; Figure 1). Clusters 1 (n=195) was associated with &gt; mild residual mitral regurgitation and worse survival performance and was characterized with worse tricuspid regurgitation severity, a higher proportion of patients with atrial fibrillation/flutter, anterior leaflet prolapse, and mitral annular/leaflet calcification, as summarized in Table 1. Conclusion TDA can identify distinct phenotype clusters with prognostic significance in MitraClip patients based on mitral valve morphology and clinical risk factors. This simple model can facilitate clinical risk stratification for MitraClip patients regarding procedural success and survival performance. Funding Acknowledgement Type of funding sources: None.
DiRA: Discriminative, Restorative, and Adversarial Learning for Self-supervised Medical Image Analysis
Haghighi, Fatemeh , Taher, Mohammad Reza Hosseinzadeh , Gotway, Michael B. , Liang, Jianming

Mayo Clinic

2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) | September 27, 2022 | Volume: No volume available | Issue: No issue available | Pages: 20792-20802

10.1109/cvpr52688.2022.02016 | PMID 36313959 Get It